NCT02994433: NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits
- State
- Under way
- Phase
- Phase 1
- People
- 60 planned
- Started
- 27 Jan 2017
- Primary completion
- 30 Apr 2027
- Arms
- Nitrous Oxide
- Results
- None posted
- 15 Dec 2016: Trial registered
- 27 Jan 2017: Trial started